Common use of Addresses Clause in Contracts

Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●], Attention: [●] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Allogene Therapeutics, Inc., 000 Xxxx Xxxxx Xxxxxx, Xxxxx Xxx Xxxxxxxxx, Xxxxxxxxxx 00000, Attention: [●] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).

Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●•], Attention: [●•] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Allogene TherapeuticsAtara Biotherapeutics, Inc., 000 Xxxx Xxxxxxx Xxxx., Xxxxx Xxxxxx, 000 Xxxxx Xxx Xxxxxxxxx, Xxxxxxxxxx XX 00000, Attention: [●•] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).

Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●•], Attention: [●•] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Allogene TherapeuticsAdverum Biotechnologies, Inc., 000 Xxxx Xxxxx XxxxxxXxxxxxxx Xxx, Xxxxx Xxx XxxxxxxxxXxxxxxx Xxxx, Xxxxxxxxxx 00000, Attention: [●•] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).

Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●·], Attention: [●·] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Allogene Therapeutics, Entasis Therapeutics Holdings Inc., 000 Xxxx Xxxxx Xxxxxx00 Xxxxxxxxx Xxxxx, Xxxxx Xxx XxxxxxxxxXxxxxxx, Xxxxxxxxxx Xxxxxxxxxxxxx 00000, Attention: [●] General Counsel (or such other address as shall be specified in writing by the Warrant Agent or by the Company).

Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●], Attention: [●] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Allogene TherapeuticsClearside Biomedical, Inc., 000 Xxxx Xxxxx XxxxxxXxxxx Xxxxxxx, Xxxxx Xxx Xxxxxxxxx000, Xxxxxxxxxx Xxxxxxxxxx, Xxxxxxx 00000, Attention: [●] Chief Executive Officer (or such other address as shall be specified in writing by the Warrant Agent or by the Company).

Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●•], Attention: [●•] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Allogene Therapeutics, Inc., 000 Xxxx Xxxxx Xxxxxx, Xxxxx Xxx Xxxxxxxxx, Xxxxxxxxxx 00000, Attention: [●•] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).

Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●], Attention: [●] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Allogene AN2 Therapeutics, Inc., 000 Xxxx Xxxxx Xxxxxx0000 Xx Xxxxxx Xxxx, Xxxxx Xxx XxxxxxxxxX, Xxxxx Xxxx, Xxxxxxxxxx 00000, Attention: [●] Chief Financial Officer (or such other address as shall be specified in writing by the Warrant Agent or by the Company).

Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●·], Attention: [●·] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Allogene Protagonist Therapeutics, Inc., 000 Xxxx 0000 Xxxxxxx Xxxx., Xxxxx 000, Xxxxxx, Xxxxx Xxx Xxxxxxxxx, Xxxxxxxxxx XX 00000, Attention: [●·] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).

Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●•], Attention: [●•] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Allogene Xxxx Therapeutics, Inc., 000 Xxxx Xxxxx Xxxxxx0000 Xxxxxx Xxxxxxxxx, Xxxxx Xxx Xxxxxxxxx000, Xxxxxxxxxx Xxxxxxxx, XX 00000, Attention: [●•] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).

Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●], Attention: [●] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Allogene Poseida Therapeutics, Inc., 000 Xxxx 0000 Xxxxx XxxxxxXxxxxx Xxxxx, Xxxxx 000, Xxx XxxxxxxxxXxxxx, Xxxxxxxxxx XX 00000, Attention: [●] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).

Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●•], Attention: [●•] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Allogene ImmunoCellular Therapeutics, Inc.Ltd., 000 Xxxx Xxxxx Xxxxxx00000 Xxxxxxx Xxxxxxxxx, Xxxxx Xxx Xxxxxxxxx0xx Xxxxx, Xxxxxxxx Xxxxx, Xxxxxxxxxx 00000, Attention: [●•] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).

Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●•], Attention: [●•] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Allogene Cidara Therapeutics, Inc., 000 Xxxx 6310 Xxxxx XxxxxxXxxxx Xxxxx, Xxxxx 000, Xxx XxxxxxxxxXxxxx, Xxxxxxxxxx 00000, Attention: [●•] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).

Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●], Attention: [●] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Allogene TherapeuticsAtara Biotherapeutics, Inc., 000 Xxxx Xxxxxxx Xxxxxxxxx, Xxxxx Xxxxxx000, Xxxxx Xxx Xxxxxxxxx, Xxxxxxxxxx 00000, Attention: [●] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).

Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●], Attention: [●] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Allogene TherapeuticsAdverum Biotechnologies, Inc., 000 Xxxx Xxxxx Xxxxxx0000 X’Xxxxx Xxxxx, Xxxxx Xxx XxxxxxxxxXxxx, Xxxxxxxxxx XX 00000, Attention: [●] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).

Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●•], Attention: [●•] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Allogene Therapeutics, Prevail Therapeutics Inc., 000 Xxxx Xxxxx 00xx Xxxxxx, Xxxxx 0000, Xxx XxxxxxxxxXxxx, Xxxxxxxxxx Xxx Xxxx 00000, Attention: [●] Chief Financial Officer (or such other address as shall be specified in writing by the Warrant Agent or by the Company).

Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●•], Attention: [●•] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Allogene ImmunoCellular Therapeutics, Inc.Ltd., 000 Xxxx Xxxxx Xxxxxx00000 Xxxxxxxxx Xxxx, Xxxxx Xxx 000, Xxxxxxxxx, Xxxxxxxxxx 00000, Attention: [●•] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).

Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●], Attention: [●] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Allogene Protagonist Therapeutics, Inc., 000 Xxxx Xxxxx XxxxxxInc. 0000 Xxxxxxx Xxxxxxxxx, Xxxxx Xxx Xxxxxxxxx000, Xxxxxx, Xxxxxxxxxx 00000, Attention: [●] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).

Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●], Attention: [●] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Allogene Marker Therapeutics, Inc., 000 Xxxx Xxxxx Xxxxxx3000 Xxxxxxxxx Xxxxxxx, Xxxxx Xxx Xxxxxxxxx0000, Xxxxxxxxxx Xxxxxxx, Xxxxx, 00000, Attention: [●] Chief Executive Officer (or such other address as shall be specified in writing by the Warrant Agent or by the Company).

Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●—], Attention: [●—] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Allogene TherapeuticsTransgenomic, Inc., 000 Xxxx Inc. 10000 Xxxxx Xxxxxx, Xxxxx Xxx XxxxxxxxxXxxxx, Xxxxxxxxxx Xxxxxxxx 00000, Attention: [●—] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).

Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●•], Attention: [●•] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Allogene Revance Therapeutics, Inc., 000 Xxxx Xxxxx 0000 Xxxxxxx Xxxxxxxxx, Xxxxxx, Xxxxx Xxx Xxxxxxxxx, Xxxxxxxxxx XX 00000, Attention: [●] Chief Executive Officer (or such other address as shall be specified in writing by the Warrant Agent or by the Company).

Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●•], Attention: [●•] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Allogene Design Therapeutics, Inc., 000 Xxxx Xxxxx Xxxxxx0000 Xxxxxx Xxxxxx Xxxx, Xxxxx Xxx Xxxxxxxxx000, Xxxxxxxx, Xxxxxxxxxx 00000, Attention: [●•] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).

Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●], Attention: [●] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Allogene TherapeuticsCytokinetics, Inc.Incorporated, 000 Xxxx Xxxxx Xxxxxx, Xxxxx Xxx Xxxxxxxxx, Xxxxxxxxxx 00000, Attention: [●] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).

Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●], Attention: [●] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Allogene Gain Therapeutics, Inc., 000 Xxxx Xxxxx XxxxxxInc. 4000 Xxxxxxx Xxxx, Xxxxx Xxx Xxxxxxxxx000, Xxxxxxxxxx Xxxxxxxx, XX 00000, Attention: [●] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).

Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●], Attention: [●] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Allogene Gain Therapeutics, Inc., 000 Xxxx Xxxxx XxxxxxInc. 0000 Xxxxxxx Xxxx, Xxxxx Xxx Xxxxxxxxx000, Xxxxxxxxxx Xxxxxxxx, XX 00000, Attention: [●] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).

Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●•], Attention: [●•] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Allogene TherapeuticsAdverum Biotechnologies, Inc.Inc. 000 Xxxxxxxx Xxx, 000 Xxxx Xxxxx Xxxxxx, Xxxxx Xxx XxxxxxxxxXxxxxxx Xxxx, Xxxxxxxxxx 00000, Attention: [●•] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).

Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●], Attention: [●] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Allogene TherapeuticsClinical Data, Inc., 000 Xxxx Xxxxx Xxx Xxxxxxx Xxxxxx, Xxxxx Xxx Xxxxxxxxx000, Xxxxxxxxxx 00000Xxxxxx, XX 00000 Attention: [●] Chief Legal Officer (or such other address as shall be specified in writing by the Warrant Agent or by the Company).

Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●•], Attention: [●•] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Allogene Design Therapeutics, Inc., 000 Xxxx Xxxxx XxxxxxInc. 0000 Xxxxxx Xxxxxx Xxxx, Xxxxx Xxx Xxxxxxxxx000, Xxxxxxxx, Xxxxxxxxxx 00000, Attention00000Xxxxxxxxx: [●•] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).

Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●], Attention: [●] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Allogene Gain Therapeutics, Inc., 000 Xxxx Xxxxx Xxxxxx4000 Xxxxxxx Xxxx, Xxxxx Xxx Xxxxxxxxx000, Xxxxxxxxxx Xxxxxxxx, XX 00000, Attention: [●] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).

Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●], Attention: [●] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Allogene TherapeuticsClinical Data, Inc., 000 Xxxx Xxxxx Xxx Xxxxxxx Xxxxxx, Xxxxx Xxx Xxxxxxxxx000, Xxxxxxxxxx Xxxxxx, Xxxxxxxxxxxxx 00000, Attention: [●] Legal Officer (or such other address as shall be specified in writing by the Warrant Agent or by the Company).

Addresses. Any communication from the Company to the Warrant Agent with respect to this Agreement shall be addressed to [●], Attention: [●] and any communication from the Warrant Agent to the Company with respect to this Agreement shall be addressed to Allogene Protagonist Therapeutics, Inc., 000 Xxxx Xxxxx XxxxxxInc. 7000 Xxxxxxx Xxxxxxxxx, Xxxxx Xxx Xxxxxxxxx000, Xxxxxx, Xxxxxxxxxx 00000, Attention: [●] (or such other address as shall be specified in writing by the Warrant Agent or by the Company).